Loading the section
The price of Pulmatrix, Inc. (PULM) on October 9, 2026 is 1.46 USD, -4.39% on the day. Over 52 weeks the stock traded between 1.16 USD and 5.24 USD; the price now sits 7% of the way up that range. Over the past year the price changed by -70.42%. Market capitalization is 5.58 million USD, rank 324 among 374 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: 15 October 2026 · Earnings calendar
Pulmatrix, Inc. trades on Nasdaq under the ticker PULM. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks PULM has traded between 1.16 $ and 5.24 $. As of 09 October 2026 the price stood 7.36 % of the way from the 52-week low to the high.
Over one year PULM shares fell 70.42 %; over six months they rose 21.67 %. Volatility over 90 days is 58.50 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 2.8, below the sector median of 3.9. Price to book is 1.6, below the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 1.47 | 1.48 | 1.43 | 1.46 | 4,361 |
| 08 October 2026 | 1.45 | 1.58 | 1.42 | 1.53 | 13,100 |
| 07 October 2026 | 1.46 | 1.51 | 1.43 | 1.49 | 11,900 |
| 06 October 2026 | 1.50 | 1.58 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
No events for this security recently.
Address:945 CONCORD STREET SUITE 1217, FRAMINGHAM, MA, 01701, US
Pulmatrix, Inc. reported revenue of 2M $ and a net loss of 5M $ over the last four quarters. Earnings per share are −2.23 $. Market capitalisation is 6M $.
PULM has a return on equity of −126.04 %, below the sector median of −41.68 %. Return on assets is −100.67 %, below the sector median of −32.11 %.
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 1.41 |
| 1.43 |
| 19,500 |
| 05 October 2026 | 1.55 | 1.59 | 1.45 | 1.48 | 24,100 |
| 02 October 2026 | 1.59 | 1.60 | 1.48 | 1.57 | 15,300 |
| 01 October 2026 | 1.54 | 1.55 | 1.50 | 1.54 | 7,900 |
| 30 September 2026 | 1.54 | 1.58 | 1.50 | 1.52 | 8,400 |
| 29 September 2026 | 1.59 | 1.63 | 1.56 | 1.56 | 7,400 |
| 28 September 2026 | 1.68 | 1.68 | 1.54 | 1.59 | 40,100 |
| 25 September 2026 | 1.64 | 1.70 | 1.60 | 1.61 | 11,900 |
| 24 September 2026 | 1.69 | 1.72 | 1.66 | 1.67 | 14,300 |
| 23 September 2026 | 1.72 | 1.76 | 1.65 | 1.69 | 29,500 |
| 22 September 2026 | 1.77 | 1.78 | 1.65 | 1.70 | 113,000 |
| 21 September 2026 | 1.39 | 1.68 | 1.39 | 1.68 | 249,500 |
| 18 September 2026 | 1.40 | 1.46 | 1.38 | 1.44 | 23,000 |
| 17 September 2026 | 1.40 | 1.43 | 1.38 | 1.43 | 14,200 |
| 16 September 2026 | 1.44 | 1.44 | 1.38 | 1.40 | 17,100 |
| 15 September 2026 | 1.43 | 1.45 | 1.41 | 1.45 | 3,400 |
| 14 September 2026 | 1.39 | 1.47 | 1.39 | 1.45 | 7,500 |